Skip to main content

Replimune Group, Inc. (REPL) Stock

Replimune Group, Inc. Stock Details, Movements and Public Alerts

Stock Details

Replimune Group, Inc. (REPL), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NMS.Currently, the stock is trading at $13.19. Over the past 52 weeks, it has ranged between $1.50 and $16.33. This places the current price at 80.8% of its 52-week high and 779.3% above its 52-week low. Recent trading volume was recorded at 1,302,970. The 14-day Relative Strength Index (RSI) stands at 47.44, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $13.15 by 0.30%. Similarly, it is above its 200-day moving average of $8.91 by 48.04%. The MACD histogram is -0.02, indicating bearish momentum (MACD Line: -0.19, Signal Line: -0.17). There is currently 1 active alert set for REPL by users.

52-Week Range

$16.33 - $1.50

-19.23% from high · +779.33% from low

Avg Daily Volume

2,165,872

20-day average

100-day avg: 4,890,835

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-6.41

Price to Book

10.39

EV/EBITDA

-3.95

EPS (TTM)

-$3.15

Beta

0.94

Less volatile than market

Q:How is REPL valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is REPL's risk profile compared to the market?
With a beta of 0.94, Replimune Group, Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 10.39 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-290,440,000

Return on Equity

-134.29%

Return on Assets

-51.30%

Q:How profitable and efficient is REPL's business model?
Profitability metrics are not available for this stock.
Q:What are REPL's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$1.2B

Shares Outstanding

94.22M

Book Value/Share

$1.26

Asset Type

EQUITY

Q:What is REPL's market capitalization and position?
Replimune Group, Inc. has a market capitalization of $1.2B, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 94.22M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does REPL's price compare to its book value?
Replimune Group, Inc.'s book value per share is $1.26, while the current stock price is $13.19, resulting in a price-to-book (P/B) ratio of 10.48. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$19.50

47.84% upside potential

Analyst Recommendations

Strong Buy

2

Buy

5

Hold

0

Sell

1

Strong Sell

0

Q:How reliable are analyst predictions for REPL?
8 analysts cover REPL with 88% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $19.50 implies 47.8% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on REPL?
Current analyst recommendations:2 Strong Buy, 5 Buy, 01 Sell, 0The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Oct 5, 2026, 02:12 AM

Technical Indicators

RSI (14-day)

47.44

Neutral

50-Day Moving Average

$13.15

0.30% above MA-50

200-Day Moving Average

$8.91

48.04% above MA-200

MACD Line

-0.19

MACD Signal

-0.17

MACD Histogram

-0.02

Bearish

Q:What does REPL's RSI value tell investors?
The RSI (Relative Strength Index) for REPL is currently 47.44, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this shows mixed signals requiring careful analysis.
Q:How should traders interpret REPL's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.19 below the signal line at -0.17, with histogram at -0.02. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($13.15) is above the 200-day MA ($8.91), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Oct 5, 2026, 01:05 AM

Active Alerts

Alert Condition
Reaches new 52-week low
Threshold
N/A
Created
May 13, 2026, 07:13 AM

Stay Ahead of the Market with Replimune Group, Inc. Alerts

Set up price alerts for Replimune Group, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.